Key result
A 6.5-cm increase in genetically determined adult height reduced the odds of coronary heart disease by 10%, with no significant association observed for stroke.
Why the study?
Does genetically determined taller adult height reduce the risk of coronary heart disease and stroke?
Meta-Analysis (n=60,028)
Yes
Does genetically determined taller adult height reduce the risk of coronary heart disease and stroke?
Answers are grounded in this paper and cite their sources.
Genetically determined taller adult height is causally associated with a lower risk of coronary heart disease, potentially mediated by better lung function and lower BMI, cholesterol, and blood pressure.
Background: We investigated causal effect of completed growth, measured by adult height, on coronary heart disease (CHD), stroke and cardiovascular traits, using instrumental variable (IV) Mendelian randomization meta-analysis. Methods: We developed an allele score based on 69 single nucleotide polymorphisms (SNPs) associated with adult height, identified by the IBCCardioChip, and used it for IV analysis against cardiovascular risk factors and events in 21 studies and 60 028 participants. IV analysis on CHD was supplemented by summary data from 180 height-SNPs from the GIANT consortium and their corresponding CHD estimates derived from CARDIoGRAMplusC4D. Results: IV estimates from IBCCardioChip and GIANT-CARDIoGRAMplusC4D showed that a 6.5-cm increase in height reduced the odds of CHD by 10% [odds ratios 0.90; 95% confidence intervals (CIs): 0.78 to 1.03 and 0.85 to 0.95, respectively],which agrees with the estimate from the Emerging Risk Factors Collaboration (hazard ratio 0.93; 95% CI: 0.91 to 0.94). IV analysis revealed no association with stroke (odds ratio 0.97; 95% CI: 0.79 to 1.19). IV analysis showed that a 6.5-cm increase in height resulted in lower levels of body mass index ( P < 0.001), triglycerides ( P < 0.001), non high-density (non-HDL) cholesterol ( P < 0.001), C-reactive protein ( P = 0.042), and systolic blood pressure ( P = 0.064) and higher levels of forced expiratory volume in 1 s and forced vital capacity ( P < 0.001 for both). Conclusions: Taller individuals have a lower risk of CHD with potential explanations being that taller people have a better lung function and lower levels of body mass index, cholesterol and blood pressure.
No takes yet. Share an insight, caveat, or question.
Nüesch et al. (2015) conducted a meta-analysis in Coronary heart disease and stroke (n=60,028). Adult height (6.5-cm increase) vs. Lower adult height was evaluated on Coronary heart disease (CHD) (OR 0.90, 95% CI 0.85-0.95). A 6.5-cm increase in genetically determined adult height reduced the odds of coronary heart disease by 10%, with no significant association observed for stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: